JP2022520183A5 - - Google Patents

Info

Publication number
JP2022520183A5
JP2022520183A5 JP2021546362A JP2021546362A JP2022520183A5 JP 2022520183 A5 JP2022520183 A5 JP 2022520183A5 JP 2021546362 A JP2021546362 A JP 2021546362A JP 2021546362 A JP2021546362 A JP 2021546362A JP 2022520183 A5 JP2022520183 A5 JP 2022520183A5
Authority
JP
Japan
Application number
JP2021546362A
Other languages
Japanese (ja)
Other versions
JP2022520183A (ja
JP7636334B2 (ja
JPWO2020163871A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/017523 external-priority patent/WO2020163871A1/en
Publication of JP2022520183A publication Critical patent/JP2022520183A/ja
Publication of JP2022520183A5 publication Critical patent/JP2022520183A5/ja
Publication of JPWO2020163871A5 publication Critical patent/JPWO2020163871A5/ja
Priority to JP2025021232A priority Critical patent/JP2025093918A/ja
Application granted granted Critical
Publication of JP7636334B2 publication Critical patent/JP7636334B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021546362A 2019-02-08 2020-02-10 治療物質の眼投与のための薬物送達組成物及びその使用法 Active JP7636334B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025021232A JP2025093918A (ja) 2019-02-08 2025-02-13 治療物質の眼投与のための薬物送達組成物及びその使用法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962803388P 2019-02-08 2019-02-08
US62/803,388 2019-02-08
PCT/US2020/017523 WO2020163871A1 (en) 2019-02-08 2020-02-10 Drug delivery compositions for ocular administration of therapeutics and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025021232A Division JP2025093918A (ja) 2019-02-08 2025-02-13 治療物質の眼投与のための薬物送達組成物及びその使用法

Publications (4)

Publication Number Publication Date
JP2022520183A JP2022520183A (ja) 2022-03-29
JP2022520183A5 true JP2022520183A5 (https=) 2023-03-03
JPWO2020163871A5 JPWO2020163871A5 (https=) 2023-03-03
JP7636334B2 JP7636334B2 (ja) 2025-02-26

Family

ID=71947905

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021546362A Active JP7636334B2 (ja) 2019-02-08 2020-02-10 治療物質の眼投与のための薬物送達組成物及びその使用法
JP2025021232A Pending JP2025093918A (ja) 2019-02-08 2025-02-13 治療物質の眼投与のための薬物送達組成物及びその使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025021232A Pending JP2025093918A (ja) 2019-02-08 2025-02-13 治療物質の眼投与のための薬物送達組成物及びその使用法

Country Status (10)

Country Link
US (1) US20220117888A1 (https=)
EP (1) EP3921420B1 (https=)
JP (2) JP7636334B2 (https=)
KR (1) KR20210138596A (https=)
CN (1) CN113710806A (https=)
AU (1) AU2020219436A1 (https=)
BR (1) BR112021015565A2 (https=)
CA (1) CA3129423A1 (https=)
MX (1) MX2021009526A (https=)
WO (1) WO2020163871A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118718181A (zh) 2019-06-05 2024-10-01 里珍纳龙药品有限公司 用于精确剂量递送的装置及方法
WO2021262645A1 (en) * 2020-06-22 2021-12-30 Ohio State Innovation Foundation Redox-responsive nanoparticle compositions for ocular delivery of therapeutics
US20230392150A1 (en) * 2020-10-13 2023-12-07 The Asan Foundation Composition for treating retinal or choroidal diseases, containing acta2 inhibitor as active ingredient
EP4317311A4 (en) * 2021-03-30 2025-04-09 Zeon Corporation CONTAINER
WO2022219089A1 (en) 2021-04-16 2022-10-20 Fondazione Istituto Italiano Di Tecnologia Polymeric microparticles for the local treatment of chronic inflammatory diseases
EP4358944A4 (en) * 2021-06-21 2025-03-12 William Marsh Rice University HIGH-YIELD PREPARATION OF PULSATILE-RELEASE MICROPARTICLES
CN113737393B (zh) * 2021-09-15 2022-06-07 陕西环保产业研究院有限公司 一种静电纺丝纳米纤维膜及其制备方法
US20230355533A1 (en) * 2022-05-06 2023-11-09 University Of Cincinnati Biodegradable polycaprolactone capsule for antibody release and degradation
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device
CN120478308B (zh) * 2025-07-17 2025-09-09 乐比(广州)健康产业有限公司 一种基于天然提取物的护眼组合物及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US7838037B2 (en) * 1999-11-17 2010-11-23 Tagra Biotechnologies Ltd. Method of microencapsulation
WO2006088473A2 (en) * 2004-04-23 2006-08-24 Panduranga Rao Koritala Microcapsules and nanocapsules for the transmucosal delivery of therapeutic and diagnostic agents
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
WO2009012303A2 (en) * 2007-07-16 2009-01-22 Northeastern University Therapeutic stable nanoparticles
CA2797110C (en) * 2010-04-22 2020-07-21 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2810842C (en) * 2010-09-09 2018-06-26 Micell Technologies, Inc. Macrolide dosage forms
US20150037422A1 (en) * 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
CA2867464A1 (en) * 2012-03-20 2013-09-26 Trustees Of Tufts College Silk reservoirs for drug delivery
WO2015142855A1 (en) * 2014-03-17 2015-09-24 University Of Virginia Patent Foundation Compositions and methods for treating retinopathy

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
JP2022520183A5 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)